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Down-regulation of surface membrane CD4 (smCD4) in phorbol ester stimulated T-cells resulted from internalization. Internalization (T1iz = 15 
min at 50 ng PMA/ml) was followed by degradation of CD4-bound antibodies. Degradation in unstimulated T-cells was comparatively insignificant. 
Release of degradation products was PMA dose-dependent and could be inhibited by methylamine. Uptake and egradation continued after maxi- 
mal down-regulation of surface membrane CD4, and methylamine did not inhibit reappearance of smCD4 antigens. Metabolic labelling of T-cells 
further showed that ongoing synthesis rather than recycling contributed to an accelerated smCD4 turnover in activated cells. 
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1. INTRODUCTION CD4 turnover in unstimulated human T-cells, as well as 
the fate and new-synthesis of smCD4 during activation. 
CD45 is a 55 kDa membrane glycoprotein, which is 
expressed in monocytes and approximately 60% of 
CD3 positive T-lymphocytes. Surface membrane CD4 
(smCD4) is known to participate in T-cell antigen 
recognition by complex-formation with monomorphic 
MHC class II determinants on antigen presenting cells 
111. Apart from this adhesive function, recent findings 
have suggested that the CD4 molecule may play an ac- 
tive role in the primary T-cell response. Thus, binding 
of anti-CD4 antibody induces transmission of specific 
intracellular signals, possibly regulating the cellular 
response to T-cell antigen receptor/CD3 complex trig- 
gering 12). Moreover, activation of T-cells by mito- or 
antigens, and in particular by phorbol esters modulates 
the surface membrane density of CD4 [3-51. It follows 
that an interconnection between T-cell responsiveness 
and the smCD4 density is likely. 
2. MATERIALS AND METHODS 
2.1. Ceil cultures 
Human mononuclear cells (PBM} and T-cells were prepared from 
defibrinated peripheral blood [8] and cultured in RPM1 1640 (Gibco, 
Paisley, UK) supplemented with glutamine, antibiotics and heat- 
inactivated human serum pool (s-RPMI). Phorbol It-myristate 
13-acetate (PMA, Sigma Chemical Co., St. Louis, MO, USA) was 
stored in dimethylsulphoxide (1 mg/ml at - 7O’C) and added to cell 
cultures at 2-50 ng/ml. 
2.2. Antibodies 
In that context the cellular handling of CD4 expres- 
sion could hold important information. Several studies 
have described the phosphorylation and pronounced 
down-regulation of smCD4 resulting from phorbol 
ester stimulation. Recent evidence has strongly in- 
dicated an endocytotic mechanism [6], but shedding of 
CD4 has been proposed as well [7]. The fact remains, 
however, that little is known with respect to CD4 
regulation in normal T-cells. 
Unlabelled monoclonal anti-CD4 antibodies (mAb1) were 
generously supplied by DakoPatts (Copenhagen, Denmark). The 
mAb1 was radioiodinated by the iodogen-technique to a specific ac- 
tivity of 800 Ci/mmol (“‘I-mAbl). 12’Iodine (1600 CVmmol) was 
from Amersham Int. (Bucks., UK). FITC conjugated monoclonal an- 
tibodies anti-Leu-3A+ 38 and anti-Leu-4A and phycoerythrin con- 
jugated anti-Leu-2A were from Becton-Dickinson (Meylan Cedex, 
France). FITC conjugated anti-CD4 and rabbit anti,mouse Ig were 
from DakoPatts. 
2.3. ‘ZsI-mAbl binding assay 
For experiments PBM and T-cells (2 x 106/ml) were incubated at 
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37°C in s-RPM1 at 50 pmoI/l L2’I-mAbl. Alternatively, the cells were 
preincubated at 4°C in a 1 @Jo bovine serum albumin (BSA) buffer (pH 
7.4) containing 50 pmolll ‘251-mAbl prior to washing (x 3) and 
resuspension in s-RPM1 at 37°C. Incubations were stopped by cen- 
trifugation on oil [9] and the amount of radioactivity associated with 
the cell pellet or found in the medium on trichloroacetic acid (TCA)- 
precipitable or -soluble form was determined in a gamma-counter [9]. 
For experiments involving methylamine (MeA), the cells were prein- 
cubated (30 mitt) in 5 mmol/l MeA prior to addition of PMA. 
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Fig. 1. Dose- and time-dependency of smCD4 modulation. Rel.fl. of 
PMA stimulated SO ng/ml (o), 10 ng/ml ( A ) and control T-cells ( q ) 
at different times during incubation. Inset shows rel.fl. of CD8 
positive ( q ), and CD4 positive cells (0) after 24 h of incubation at 
37°C with PMA at concentrations indicated. 
2.4. Flow-cytometric analysis 
Cells were stained with fluorescent antibodies as suggested by the 
manufacturers. Relative fluorescence (relfl.) was determined accor- 
ding to the equation: 
The flow-cytometer (FACScan, Becton-Dickinson, USA) was used in 
logarithmic mode of 1024 channels at a maximum reading of 104 
units. Internalized CD4 was defined by the following procedure: T- 
cells were incubated with 5 nmol/l unlabelled mAb1 (4”C, 10 h) and 
subsequently washed 3 times in cold buffer. At zero time the cells were 
resuspended in warm (37°C) s-RPM1 with or without 50 ng PMA/ml, 
and at given times the reaction was stopped by addition of a surplus 
of cold buffer. The cells were washed (X 3), labelled with FITC anti- 
mouse Ig (DakoPatts), and the amount of anti-CD4 Ig on cell surfaces 
was determined by flor-cytometry. The difference between fluores- 
cence on unactivated cells and that on PMA activated cells, that is the 
amount of CD4 which could no longer be detected in activated cells, 
was defined as internalized antigen. Intracellular CD4 was detected in 
cells made permeable for FITC-mAb1 by treatment with digitonin. 
Digitonin (Sigma) was purified as described elsewhere [lo] and used 
at an optimal concentration of 0.4 mg/ml. 
2.5. Metabolic labelling 
T-cells (4x 106/500 pl) were incubated with or without 50 ng 
PMA/ml in methionine-free RPM1 1640 supplemented with 0.05% 
dialysed fetal calf serum (FCS) and 200 pCi [“Slmethionine (Amer- 
sham). After 6 h of incubation the cells were washed (x 3, 4’C) and 
lysed in 1% Triton X-100 (Boehringer, Mannheim, FRG) lysis buffer 
(pH 8.0) in the presence of 2 mmol/l PMSF (Sigma). Labelled protein 
was precipitated by incubation (4°C) with mAb1 fixed on im- 
munomagnetic beads (DynaBeads, Dynal, Oslo, Norway). After ex- 
tensive washing the beads were pelleted, resuspended in 100 ~1 reduc- 
ing sample buffer (5% v/v mercaptoethanol, 4% SDS) and boiled for 
1 min. The samples were subjected to SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) in a Laemmli system using a 4% stacking 
and 15% separation gel. Molecular weight markers were from Sigma. 
PPO-fluorographies were examined by densitometry (Dual 
wavelength TLC scanner, Shimadzu). 
3. RESULTS 
3.1. PMA induced down-regulation of smCD4 
Activation of separated and unseparated T-cells by 
PMA rapidly reduced CD4 presentation. Down-regula- 
tion was dose- and time-dependent (Fig. l), and elapsed 
with a half-time of approximately 60 min at 50 ng 
PMA/ml. In 8 h smCD4 density had reached an ap- 
pearent minimum at 8.2 + 1.7% (n = 3) of that in 
unstimulated controls. Similar findings resulted from 
estimates based on ‘251-mAb1 binding (at 4°C) to 
PMA-blasts (not shown). Activation also affected the 
surface membrane density of CD8 antigens in CD8 + T- 
cells although the effect was less pronounced (inset Fig. 
1). PMA-induced down-regulation of smCD4 in MeA 
treated T-cells did not differ from that in untreated 
cells. Yet, >80% of prebound (at 4°C) 1251-mAb1 re- 
mained associated to MeA treated cells even after 4 h 
with PMA (Table I), indicating the involvement of an 
endocytotic process. FACS analysis of activated cells 
also indicated internalization of CD4 antigens (Fig. 2). 
Thus, the reduction in smCD4 fluorescence was partly 
compensated for by an increase (> 25% at 60 min) in 
fluorescence following digitonin treatment. Detection 
of CD4 and CD8 in control T-cells was unaltered by 
digitonin, indicating low intracellular pools of CD4 and 
CD8 antigens in unactivated cells. After 16 h of PMA 
activation digitonin-treated cells did not express detec- 
table intracellular CD4 reactivity, suggesting adramatic 
reduction in total cellular CD4. 
Table 1 
Cells were preincubated with or without 50 pmol/l ‘ZSI-mAbl at 4°C for 16 h prior to washing (x 3). Cells 
were resuspended at 37°C with or without PMA (50 ng/ml). PMA stimulated cells were incubated with or 
without MeA 
‘Z’I-mAbl in pellet smCD4 (rel.fl.) TCA-soluble rz51 
Contr. PMA PMA + MeA Contr. PMA PMA + MeA Contr. PMA PMA + MeA 
(1) 71.0% 7.2% 84.4% 100% 6.9% 9.6% 13.4% 68.3% 8.8% 
(2) 54.5% 1.6% 40.6% 99.1% 21.3% 18.8% 
(1) After 5 hours of incubation cell-associated radioactivity (‘251-mAbl in pellet) and TCA-soluble radioac- 
tivity of the medium was determined (mean of triplicate samples in percent of prebound radioactivity). 
Parallel cultures were analysed after FITC-anti-CD4 staining, and rel.fl. was determined (smCD4) (2) All 
cultures were washed at 4°C (x 3) and reincubated without PMA, but with or without MeA as indicated. The 
cells were cultured for 12 h at 37’C to allow reexpression of smCD4. 
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Fig. 2, Detection of int~ceIl~lar CD4 antigens during PMA stimuI~- 
tion. Anti-CD4 fluorescence (mean channel) of T-091s incubated with 
or without (n) 50 ng PMA/ml. PMA srimuiated cells were 
Leu-3a + 3b (FKTC) stained in the absence (0) or presence ( a ) of 0.4 
mg di~it~ni~~ml. 
As demonstrated in Fig* JA inter~ali~~tio~ followed 
first-order kinetics with an estimated half-time of 15 
min. Internalization was faster than CD4 surface densi- 
ty down-regulation, indicating PMA induced recycling 
or, more likely, new-synthesis of CD4 antigens (Table 
I). Fig. 3A shows the results of an experiment in which 
T-cells were incubated (at 4OC) with ‘2SI-mAb1 and 
subsequently stimulated with 50 ng PMA/ml at 37’C 
After a lag time of about 30 min TCA-soluble radioac- 
tivity {degraded products) appeared in the medium 
following a sigmoidal curve, and activity in the cell 
pellet decreased accordingfy. Fig. 3l3 shows the PMA 
dose-dependency of ‘2SI-mAbl degradation. Degrada- 
tion rate constant of controls was 0.4 x 10 - s min - ’ ver- 
sus 8,4x 10s3 min-” at 50 ng PMA/ml. 
At 37’C i2%mAbl was taken up by activated T-c&s 
and degradation products appeared in the medium (Fig, 
4A). In spite of a high tracer uptake, release of TCA- 
soluble products was much lower in unactivated cells. 
Cells stimulated for 36 or 96 h prior to incubation with 
tracer released radioactive degradation products at a 
constant rate, which, in spite of low smCD4 levels, ex- 
ceeded that in control cells (not shown). TCA-soluble 
radioactivity was insignifi~~~~ upon 24 h of ~n~nbatioR 
with CD4 negative cells (K562). These experiments 
clearly demonstrate that CD4 mofecules constantly 
reappear on the cell surface either due to recycling or 
new-synthesis. 
Metabolic labelling of T-cell cultures in the absence 
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Fig. 3. (A) PMA-induced degradation of prebound “‘I-anti-CD4. 
Cells were incubated with “%mAbl at 4’C, washed and resuspended 
at 37°C. Cell-associated ra~o~ctivity (filled ssrnb~~s) and TCA- 
sofuble radioactivity released in the medium (open symbols) by con- 
trol ( q ) and PMA stimulated T-&s (0) were determined at times in- 
dicated. (Tnsetf Internaked CD4 and total smCD4 at given times dur- 
ing PMA (SO ng!mml) stimulation of T-cells. (B) PMA dose- 
dependency of anti-CD4 antibody degradation. TCA-soluble radioac- 
tivity in percent of prebound t2%mAbl (at 4°C). Release from T-cells 
(2 x l~6/m~) in response to different concentrations of PMA is 
shown as a function of time of in~ubat~an. 
or presence of PMA indicated enhanced CD4 synthesis 
in PMA-blasts. Thus, the amount of immunoprecipi- 
table, CD~-incorporated [~~S~methionine was higher in 
PMA-blast Iysates than in lysed unstimul~ted celts. It 
follows that activated cells contained at least as much 
newly synthesized CD4 as unstim~lated cells, in spite of 
the reduced CD4 half-life pig. 4B). 
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Fig, 4. [A) LJptake and degradation of anti-CD4 antibody. ‘%nAbJ 
was added at zero time to PMA stimulated (0) and control ( q ) T- 
cells. Cell associated (filled symbols) and TCA-soluble radioactivity 
(open symbols) at different times are indicated. (B) New-synthesis of 
CD4 antigens in PMA activated and controf T-cell. BioIabdled CD4 
antiigens ~~~~~op~~c~~j~~~~ from cultures of PMA-a~ivated @3 
ngimf) and control human T-cehs. 
4, DISCUSSION 
Recent findings have ~t~bIis~~d th CD4 antitigens in 
pborbof ester and antigen ~t~~u~at~d CeSS are gbuS@l* 
ryIated via protein kinase C and sub~equ~~t~y down- 
regulated [ 11,12]. CD4-down-regulation has been 
ascribed to shedding [7], impaired new-synthesis [13], 
and internalization [t&l l] but evidence concerning post- 
activation events are scarce. Tfie presezzt study dcmon- 
stratus that smCD4 is in fact down-regulate by way of 
internalisatian. Moreover, experiments involving 
labelled ligand (mAb1) indicate that the CotJ pool of 
CD4 in activated cells is reduced by rapid degradation 
of internalized antigen. CD4 is also interna&zed and 
degraded in restimulate T &Is, but at a much Iower 
rate. The data indicates &at activation by PMA (50 
ngjml) increased the degrada~o~ rate instant by 
20-fold. A minimum smCD4 density of 5-l@% was 
detected in activated celh. Evidently recycling WC CD4 
antigens cannot be excluded, but in contrast to Richie et 
al. 1131 our findings strongly suggest that n unchanced 
or increased synthesis contribute to the co#inued 
presentation of smCD4 in P&IA activated cells, Thus, 
continued synthesis of CD4 antigens may contribute to 
the ‘recovery” of cells from PMA induced CD4 down- 
regulation, which has been ascribed to down-regulation 
of phorbol ester receptors 161. In conclusion, smCD4 in 
resting T-celIs is characterized by a slow turnover and a 
half-life exceeding 24 h. Upon activation, cataboIism 
(possibly by lysasomal degradation) is drastically in- 
creased with internalisation as the rate limiting step. A 
partly compensating increase in new-synthesis con- 
tributes to an accelerated turnover at a new steady state 
and a lower smCD4 density. Infection of CD4 + cells by 
I-IIV does not require internal~sati~n of CD4 antigens 
]11,14}; in fact, the decreased infectivity of phorbol 
ester stimulated cells might reflect the down-regulation 
af HIV attachment [15,16], and perhaps even degrada- 
tion of CD4-associated virus. 
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